Boston Scientific Corporation

BSX Healthcare Medical Devices

Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

44.39 0.25 +0.57%
Market cap
$64.0B
P/E
17.9×
Fwd P/E
17.8×
Dividend yield
—
F-score
7/9
Altman Z
5.41
Beneish M
−2.49
Dividend safety
n/a

Boston Scientific Corporation (BSX) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Boston Scientific Corporation (BSX) trades at a P/S ratio of 3.1×. Over the past ten years it has ranged from 2.4× (January 2015) to 9.3× (February 2025); the current reading is higher than 5% of that period. That is above the Medical Devices industry median of 2.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 7.0× (10.40%)
FY2024 7.8× 32.98%
FY2023 5.9× 13.72%
FY2022 5.2× 2.11%
FY2021 5.1× (1.08%)
FY2020 5.1× (12.35%)
FY2019 5.9× 17.98%
FY2018 5.0× 29.79%
FY2017 3.8× 8.07%
FY2016 3.5× 7.09%

Quarterly newest first

Period P/S ratio Change
Jun 2026 3.0× (33.88%)
Mar 2026 4.5× (35.72%)
Dec 2025 7.0× (5.94%)
Sep 2025 7.5× (13.02%)
42 more quarters

Against its own ten years

Low 2.4× High 9.3×
Ten-year median 5.2×
Current reading's percentile 2

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.5×
BSX Boston Scientific Corporation 3.1×
MDT Medtronic PLC compare 3.2×
STE STERIS plc compare 3.6×
ABT Abbott Laboratories compare 3.9×
SYK Stryker Corporation compare 4.4×
DXCM DexCom, Inc. compare 6.6×
EW Edwards Lifesciences Corporation compare 7.7×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on BSX